| ²é¿´: 193 | »Ø¸´: 2 | |||
| µ±Ç°Ö÷ÌâÒѾ´æµµ¡£ | |||
yyhh0818ͳæ (СÓÐÃûÆø)
|
[½»Á÷]
ÖÐÎÄÕªÒª·Òë
|
||
|
Îå»·ÈýÝÆÀ໯ºÏÎïÊÇÒ»ÀàÔÚ×ÔÈ»½çÖй㷺´æÔÚ²¢¾ßÓжàÖÖÉúÎï»îÐԵĵ¥Ì壬¿¹Ö×Áö×÷ÓÃÊÇÆäÖ÷ÒªµÄ»îÐÔÖ®Ò»¡£Ëü¾ßÓÐÒÖÖÆÖ×Áöϸ°ûÔöÖ³¡¢ÓÕµ¼Ö×Áöϸ°ûµòÍö¡¢Äæ×ªÄÍÒ©¼°¿¹Ñª¹ÜÉú³ÉµÈ×÷Óã¬ÒòÆä×÷ÓûúÖÆ¸´ÔÓ¶àÑù£¬´æÔÚ¶à¸ö×÷Óðе㣬ÒѳÉΪһÀ༫¾ßDZÁ¦µÄ¿¹Ö×ÁöÏȵ¼»¯ºÏÎïÒýÆð¹ú¼ÊÉÏ¿¹Ö×ÁöÒ©ÎïÑо¿ÁìÓòµÄ¹ã·º¹Ø×¢¡£ÏÖ¾ÍÆäÔÚ½üÄêÀ´µÄ¿¹Ö×Áö×÷ÓûúÖÆ·½ÃæµÄÑо¿½øÐÐ×ÛÊö¡£ Çë´ó¼Ò°ïÎÒ·Òë³ÉÓ¢ÎÄ£¬¸Ð¾õ×Ô¼º·ÒëµÄ²»Ì«ºÃ¡£·Ç³£¸Ðл£¡ |
» ²ÂÄãϲ»¶
²ÄÁÏ¿¼ÑÐÇóµ÷¼Á×Ü·Ö280
ÒѾÓÐ3È˻ظ´
Çóµ÷¼Á
ÒѾÓÐ4È˻ظ´
²ÄÁϵ÷¼Á
ÒѾÓÐ10È˻ظ´
Çóµ÷¼Áµ½²ÄÁÏ
ÒѾÓÐ3È˻ظ´
»¯¹¤Çóµ÷¼Á£¡
ÒѾÓÐ9È˻ظ´
301Çóµ÷¼Á
ÒѾÓÐ13È˻ظ´
308Çóµ÷¼Á
ÒѾÓÐ13È˻ظ´
²ÄÁϹ¤³Ì310ר˶µ÷¼Á
ÒѾÓÐ15È˻ظ´
304Çóµ÷¼Á
ÒѾÓÐ9È˻ظ´
081700£¬311£¬Çóµ÷¼Á
ÒѾÓÐ16È˻ظ´
jerry.lubo
ľ³æ (ÖøÃûдÊÖ)
- Ó¦Öú: 0 (Ó×¶ùÔ°)
- ½ð±Ò: 3151
- É¢½ð: 29
- ɳ·¢: 1
- Ìû×Ó: 1749
- ÔÚÏß: 165.3Сʱ
- ³æºÅ: 545425
- ×¢²á: 2008-04-14
- ÐÔ±ð: GG
- רҵ: Ï𽺼°µ¯ÐÔÌå
¡ï ¡ï ¡ï ¡ï ¡ï ¡ï ¡ï ¡ï ¡ï ¡ï
yyhh0818(½ð±Ò+10,VIP+0):·Ç³£¸Ðл! 3-19 00:31
yyhh0818(½ð±Ò+10,VIP+0):·Ç³£¸Ðл! 3-19 00:31
|
Pentacyclic triterpenoids which have a wide range of biological activity is a class of widely exist in nature,and the anti-tumor effect is one of its main activities. It works in inhibiting tumor cell proliferation and angiogenesis, inducing tumor cell apoptosis and reversaling of drug resistance. As its complex and diverse mechanism which contains several targets,the pentacyclic triterpenoids has become a lead class of potential anti-tumor compounds and caused global extencive attention on the field of antineoplastic drugs. The paper reviews the mechanism of anti-tumor research in recent years. |
2Â¥2009-03-18 18:43:55
jerry.lubo
ľ³æ (ÖøÃûдÊÖ)
- Ó¦Öú: 0 (Ó×¶ùÔ°)
- ½ð±Ò: 3151
- É¢½ð: 29
- ɳ·¢: 1
- Ìû×Ó: 1749
- ÔÚÏß: 165.3Сʱ
- ³æºÅ: 545425
- ×¢²á: 2008-04-14
- ÐÔ±ð: GG
- רҵ: Ï𽺼°µ¯ÐÔÌå
3Â¥2009-03-19 18:50:12














»Ø¸´´ËÂ¥